Abnormalities in lysine degradation are involved in early cardiomyocyte hypertrophy development in pressure-overloaded rats

被引:0
作者
Jialing Liu
Junhao Hu
Lanlan Tan
Qi Zhou
Xiaojing Wu
机构
[1] Cardiovascular Department of the Second Affiliated Hospital of Chongqing Medical University,
[2] Cardiovascular Department of Shenzhen University General Hospital and Shenzhen University Clinical Medical Academy,undefined
来源
BMC Cardiovascular Disorders | / 21卷
关键词
Cardiac hypertrophy; Pressure overload; Lysine degradation; Metabolomics; Nonenergetic metabolism;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 75 条
  • [1] Shimizu I(2016)Physiological and pathological cardiac hypertrophy J Mol Cell Cardiol 97 245-262
  • [2] Minamino T(2018)Mechanisms of physiological and pathological cardiac hypertrophy Nat Rev Cardiol 15 387-407
  • [3] Nakamura M(2016)Epidemiology and aetiology of heart failure Nat Rev Cardiol 13 368-378
  • [4] Sadoshima J(2018)Cardiomyocyte gene programs encoding morphological and functional signatures in cardiac hypertrophy and failure Nat Commun 9 4435-1127
  • [5] Ziaeian B(2019)Highlights in heart failure ESC Heart Fail 6 1105-871
  • [6] Fonarow GC(2017)Complex energy metabolic changes in heart failure with preserved ejection fraction and heart failure with reduced ejection fraction Can J Cardiol 33 860-448
  • [7] Nomura S(2007)Metabolic mechanisms in heart failure Circulation 116 434-1031
  • [8] Satoh M(2014)Energy metabolic reprogramming in the hypertrophied and early stage failing heart: a multisystems approach Circ Heart Fail 7 1022-H431
  • [9] Fujita T(2020)In vivo [U-13C]glucose labeling to assess heart metabolism in murine models of pressure and volume overload Am J Physiol Heart Circ Physiol 319 H422-1616
  • [10] Tomasoni D(2019)Increased ketone body oxidation provides additional energy for the failing heart without improving cardiac efficiency Cardiovasc Res 115 1606-167